Search Results
Found 64 results for "technology" across articles, medicines, trials, companies and the glossary
MedicinesAll 10 →
BEKEMV 300 mg Concentrate for solution for infusionEculizumab · Amgen Technology (Ireland) Unlimited Company
MVASI 25 mg/mL Concentrate for solution for infusionBevacizumab · Amgen Technology (Ireland) Unlimited Company
PAVBLU 40 mg/mL solution for injection in a vialAflibercept · Amgen Technology (Ireland) Unlimited Company
PAVBLU 40 mg/mL solution for injection in pre-filled syringeAflibercept · Amgen Technology (Ireland) Unlimited Company
Ryzneuta 20 mg solution for injectionEfbemalenograstim alfa · Evive Biotechnology Ireland Limited
Voltfast Sachets 50mg Powder for Oral SolutionDiclofenac potassium · Wisdom Pharmaceutical Technology Co Limited
Clinical trials in IrelandTracker →
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the F…Active · Boston Scientific Corporation
GlossaryAll terms →
PATProcess Analytical Technology.
CRISPRClustered Regularly Interspaced Short Palindromic Repeats. A gene-editing technology allowing precise edits t…
Single-Use TechnologyDisposable manufacturing equipment components (such as bags and connectors) used in place of traditional stai…
Industry
Dixon Technologies Secures 220 Million USD Corporate Guarantee for Lenovo Ireland IT Hardware Manufacturing
Dixon Technologies has issued an irrevocable corporate guarantee of 220 million USD on behalf of its subsidiary Padget Electronics in favor of Lenovo Ireland to secure IT hardware component procurement.
Industry
TMC Pharma Services Acquires tranScrip to Expand Global Life Science Regulatory and Medical Consulting Capabilities
TMC Pharma Services has acquired contract drug development organization tranScrip, combining clinical trial execution and contract research with deep regulatory affairs, medical, and scientific advisory services.
Industry
William Fry Advises PerkinElmer on Strategic Acquisition of Irish Life Science Automation Leader SimoTech
Project Farma, a division of PerkinElmer, has entered into a definitive agreement to acquire SimoTech, combining commissioning and validation expertise with Cork-based manufacturing automation and GMP IT systems.
Industry
From Lab Bench to DeltaV: The Highest-Paying Tech & Automation Roles in Irish Biomanufacturing
An analysis of the digital transformation reshaping Irish biomanufacturing. How hybrid skills in DeltaV, Manufacturing Execution Systems (MES), SCADA, and AI-driven process engineering command a 35% salary premium across Dublin and Cork facilities.
Industry
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
A comprehensive guide to utilizing Priya Life Science's live trackers. Learn how to track clinical trials, regulatory recalls, drug shortages, biotech layoffs, and M&A venture activity to accelerate your career and optimize market intelligence.
Industry
Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
An in-depth analysis of Ireland's €93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.
Industry
Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing
University of Limerick-hosted Rinn Pharma & Biopharma has partnered with NordicPharmaTrain (NPT), a premier European research and training consortium. The milestone collaboration enhances Ireland's global leadership in advanced crystallization, digital manufacturing, sustainable drug formulation, and cross-border researcher mobility.
Industry
Moving from India to Ireland in 2026: The Definitive Education, Visa, Relocation, and Career Master Guide for Indian Students & Professionals
An exhaustive, 5,000+ word master guide for Indian students, life science graduates, and working professionals moving to Ireland in 2026. Covers Stamp 2 & Stamp 1G post-study work visas, CSEP permits, university selection, VFS Global India processing, PCC, financial proof, housing scam warnings, and ethical career entry into Ireland's €100B+ biopharma sector.
Industry
Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
An in-depth evaluation of Donald Trump’s scheduled September visit to Ireland, examining the Doonbeg Irish Open itinerary, security logistics, protectionist tariffs, corporate tax policy friction, and strategic implications for U.S.-Irish bilateral relations.
Industry
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
Industry
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
In a major boost for Ireland’s Mid-West life sciences hub, US biopharma specialist Pfanstiehl has acquired Nestlé’s former Wyeth Nutritionals plant in Askeaton, Co. Limerick, establishing its first international manufacturing facility.
Industry
ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion
OpenAI secures an 88,000 sq ft lease at IPUT's iconic Tropical Fruit Warehouse on Sir John Rogerson's Quay, bringing 250 new high-tech jobs to Dublin as it expands its European headquarters.
Industry
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.
Industry
The Resource Equation: Decoupling Water, Power, and the Shift in Ireland’s Data Centre and Life Sciences Footprint
An in-depth, fact-based analysis of water and power consumption across Ireland’s twin industrial pillars, the infrastructure bottlenecks, and the shifting geography of high-tech construction.
Industry
Quantum 2030: How Ireland’s New Strategic Blueprint Aims to Secure Global Leadership in Quantum Computing
The Irish Government launches "Quantum 2030", a whole-of-government national strategy designed to position Ireland as an internationally competitive hub in quantum technologies, research, and talent by 2030.
Industry
ABPI Impact Map Highlights £20.4B Pharma Footprint as UK-Ireland Supply Chain Synergies Deepen
The ABPI launches its updated 2026 Pharmaceutical Impact Map, revealing a £20.4bn economic contribution, 125,702 skilled jobs, and 3,658 NHS collaborations across the UK, while underscoring vital cross-border manufacturing and trade synergies with Ireland.
Industry
GEODIS Expands European Logistics Network with 2,000-Pallet Temperature-Controlled Manchester Pharma Hub
GEODIS opens a state-of-the-art GDP-compliant pharmaceutical hub in Sharston Green, South Manchester, offering 2,000 pallet positions, 15-25°C and 2-8°C climate-controlled storage, and direct air/sea connectivity to Ireland and global markets.
Industry
Registrations Open for TechIreland National AI Challenge 2026: Agentic Workflows, Regional Hubs, and Ecosystem Collaboration
Registrations are now open for the 2026 TechIreland National AI Challenge, delivered in partnership with CeADAR, Enterprise Ireland, and the European Digital Innovation Hubs Network. Learn about the 2026 theme "AI & Agents", key deadlines, regional hubs, and how to register.
Biotechnology
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.
Industry
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
The definitive 2026 guide to writing an ATS-compliant biopharmaceutical CV in Ireland and the EU. Features HPRA & EU Annex 1 standards, GxP bullet point formulas, Irish regional hub insights, and free ATS CV Studio tools.
Industry
Enterprise Ireland Funding Programmes 2026: The Complete Founder’s Guide to Grants, Pre-Seed (PSSF), iHPSU & Founder Visas
Master Enterprise Ireland's funding ecosystem: from Pre-Seed Start Fund (€50k-€100k) and Innovative HPSU Fund (€1.2M) to R&D, Green, and Digitalisation vouchers. Includes step-by-step application advice, readiness timelines, and non-EU founder visa rules.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
Regulatory Affairs
Transatlantic Tariff Siege: EU Pushes US for €150B Exemption List to Protect MedTech and Spirits
As the Turnberry Deal’s 15% tariff baseline takes hold, Brussels has formally requested carve-outs for €150 billion worth of European goods. The stakes are exceptionally high for Ireland’s €13B medical technology industry, where critical components face severe transatlantic margin pressures.
Biotechnology
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Ireland’s goods exports fell by 29.1% to €16.5 billion in May 2026, driven by a €8 billion drop in pharmaceutical shipments, while imports rose 17.5% to €13.1 billion, narrowing the trade surplus.
Biotechnology
Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips
Dublin-based Pilot Photonics receives up to €10.4 million in EIC Accelerator funding to scale high-volume manufacturing of its patented photonic integrated circuits (PICs) for AI data centres, satellite transceivers, and 6G networks.
Industry
Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare
Intel has announced a massive €5 billion ($5.7 billion) capital investment at its Leixlip campus in Ireland to expand semiconductor manufacturing capacity, driven by global demand for AI and high-performance computing.
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
Industry
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.
Pharmaceutical
The Complete LinkedIn Brand-Building Playbook for Pharma and Life Sciences
LinkedIn is the most powerful platform for pharmaceutical and life sciences professionals to build authority and reach target customers. This complete guide covers company page setup, what to post, best times to publish, how to grow connections, and how to turn LinkedIn into a consistent pipeline.
Pharmaceutical
The Newsletter Advantage: How Pharma Companies Use Email to Reach the Right People Every Time
Newsletters are the most cost-effective marketing tool for pharmaceutical companies. Unlike social media, a newsletter lands directly in the inbox of every person who chose to hear from you. This step-by-step guide explains how to set one up, what to put in it, and how to reach target customers efficiently.
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
Regulatory Affairs
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
Jefferies has revised its debut-quarter US sales estimate for Eli Lilly's oral GLP-1 drug Foundayo (orforglipron) down to $71 million - well below the Wall Street consensus of $130 million and sharply below its own prior estimate of $85 million. With weekly prescriptions hovering around 20,000 and Novo Nordisk's oral Wegovy outpacing it on trajectory, the first oral non-peptide GLP-1 for obesity is generating a very different story than the hype suggested.
Regulatory Affairs
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
The UK government and the pharmaceutical industry have launched a series of pilot schemes designed to accelerate NHS patient access to innovative medicines - a direct consequence of the US-UK pharmaceutical trade arrangement that has already rewritten the terms of how Britain prices, approves, and funds new drugs. But with a BMJ analysis warning of £45 billion in diverted NHS resources and up to 229,000 excess deaths by 2036, the pilots are arriving in the middle of one of the most contested healthcare policy disputes in a generation.
MedTech
Cork MedTech Innovator NeuroBell Secures $5.5M to Accelerate Launch of AI Neonatal Seizure Monitor Luna
NeuroBell, a spin-out from University College UCC, has closed a $5.5 million (€4.8 million) funding round led by Elkstone to secure US regulatory clearance and commercialize its AI-powered neonatal seizure detection device, Luna.
Industry
Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders
Co-founded by Patrick Murphy and David Kelly, Tapestry VC has announced the closing of its $80 million Fund III, tripling its capital base with support from OpenAI CFO Sarah Friar and the British Business Bank.
MedTech
AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows
Build, a startup co-founded by James Stirrat-Ellis and Ben McClusky, has secured $8.5 million in seed funding led by Index Ventures to expand Dougie, its AI platform for real estate infrastructure workflows.
Industry
GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks
Co-founded by Habs Isabelle Kim and Dermot O'Riordan, government technology startup Xylo has raised £2.8 million in pre-seed funding to deploy AI agents that speed up local planning departments.
Regulatory Affairs
The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026
A comprehensive technical report detailing the top 10 trends in Good Manufacturing Practice (GMP), sterile manufacturing, GAMP 5, Quality 4.0, and continuous manufacturing currently reshaping the global pharmaceutical landscape.
Industry
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
An in-depth analysis of two newly opened funding opportunities-Women TechEU and Innovate UK's Next Wave Createch-designed to support early-stage deep tech and creative technology innovators across Europe and the UK.
Pharmaceutical
Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines
An academic analysis of temperature-sensitive supply chains, GDP compliance, distribution monitoring, and shipping deviation management.
Regulatory Affairs
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
As global health systems enforce tighter pricing controls under the US IRA and EU health technology updates, biopharma majors are restructuring their R&D portfolios to manage clinical risks.
Pharmaceutical
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
An academic analysis of the freeze-drying process, sublimation phases, critical chamber controls, and lyophilized formulation parameters.
Pharmaceutical
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
An exhaustive guide detailing postgraduate Level 9 pharmaceutical master's programs across Irish universities, covering tuition fees, eligibility criteria, and requirements for international applicants.
Industry
Global Biopharma M&A Rebounds in 2026: AbbVie and Merck KGaA Lead Multi-Billion Dollar Acquisitions
Global pharmaceutical dealmaking has surged in 2026 as cash-rich majors AbbVie and Merck KGaA close multi-billion dollar acquisitions to restock pipelines ahead of late-decade patent cliffs.
Regulatory Affairs
B2B Scaling Roundtable: Fieldfisher to Host Dublin Tech Founders on July 1st
Legal firm Fieldfisher will host a scaling roundtable for B2B founders and sales leaders in Dublin on July 1st, featuring legal guidance from Jamie Woodcock and leadership coaching from Fergus McFadden.
Industry
MedTech Pioneer CroíValve Closes $27 Million Series B Expansion to Advance Transcatheter Tricuspid Heart Valve Treatment
Dublin-based medical device developer CroíValve has secured a $27 million expansion of its Series B round, combining equity funding led by BGF and state grants to accelerate US and EU clinical trials for its DUO Adapt System.
MedTech
Ubotica Secures $11 Million to Roll Out Satellite-Based Orbital AI Maritime Intelligence Platform
Space-tech leader Ubotica has closed an $11 million funding round led by Act Venture Capital and Greencode Ventures to scale its real-time Live Maritime Intelligence platform powered by direct satellite AI processing.